Replies to post #321349 on Avid Bioservices Inc (CDMO)

[geocappy1]

Yeah, we have very little upside too

[shipbuilder]

Steve King's legacy will be tied foremost to any one, two or all of Bavituximab, Beta Bodies, and the Exosome Test resulting in positive outcomes for patients. Secondly, and likely more relevantly to those reading this post, his legacy is tied to the realized value of the IP over the near term.